EP Patent

EP0325086A2 — Novel methods for obtaining therapeutic systems with controlled release of the drug

Assigned to Jago Research AG · Expires 1989-07-26 · 37y expired

What this patent protects

Therapeutic system for the controlled rate release of drugs, characterized by: 1. a polymeric matrix consisting of hydrophilic, swelling, natural and/or synthetic, biocompatible polymers containing the therapeutically active dose of drug, 2. a polymeric barrier applied on …

USPTO Abstract

Therapeutic system for the controlled rate release of drugs, characterized by: 1. a polymeric matrix consisting of hydrophilic, swelling, natural and/or synthetic, biocompatible polymers containing the therapeutically active dose of drug, 2. a polymeric barrier applied on said matrix and bound to decompose when in contact with aqueous fluids which controls the flow of the fluids into the interior of the system only at the beginning of the release period.

Drugs covered by this patent

Patent Metadata

Patent number
EP0325086A2
Jurisdiction
EP
Classification
—
Expires
1989-07-26
Drug substance claim
No
Drug product claim
No
Assignee
Jago Research AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.